Medexus Pharmaceuticals, Inc. (MDP.TO)
2.81
-0.03
(-1.06%)
CAD |
TSX |
Feb 11, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 91.10M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -13.54% |
| Valuation | |
| PE Ratio | 130.09 |
| PE Ratio (Forward) | |
| PS Ratio | 0.5638 |
| Price to Book Value | 1.249 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.4019 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 90.82% |
Profile
| Medexus Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products and treatment solutions focusing on therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. The firm products include IXINITY, Rasuvo, Metoject, Rupall, and Gleolan. The company was founded in 2003 and is headquartered in Toronto, Canada. |
| URL | http://www.medexus.com |
| Investor Relations URL | https://www.medexus.com/en_US/investors |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | N/A |
| Last Earnings Release | Feb. 11, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Medexus Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products and treatment solutions focusing on therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. The firm products include IXINITY, Rasuvo, Metoject, Rupall, and Gleolan. The company was founded in 2003 and is headquartered in Toronto, Canada. |
| URL | http://www.medexus.com |
| Investor Relations URL | https://www.medexus.com/en_US/investors |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | N/A |
| Last Earnings Release | Feb. 11, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |